Over 21.58 crore COVID-19 vaccine doses administered in India

The cumulative number of doses of the COVID-19 vaccine administered in the country has exceeded 21.58 million rupees, the Union Health Ministry said on Monday. It said 12,23,596 people in the 18 to 44 age group received their first dose and 13,402 their second dose of the Covid vaccine on Monday.

In total, 2,02,10,889 people across the country have received their first dose and 23,491 their second dose since the start of phase three of the vaccination campaign, the ministry said.

Bihar, Delhi, Gujarat, Haryana, Karnataka, Madhya Pradesh, Maharashtra, Rajasthan, Tamil Nadu, Uttar Pradesh, and West Bengal have given more than 10 lakh beneficiaries in the 18-44 age group their first dose of the COVID vaccine -19. He said.

The cumulative number of COVID-19 vaccine doses administered in the country has reached 21,58,18,547, according to the interim report of 7:00 p.m. today, the ministry reported.

The total of 21,58,18,547 includes 98,83,778 health workers (HCWs) who have taken their first dose and 67,87,633 HCWs who have taken their second dose and 1,56,67,311 first-line workers (PDA) who have received their first dose and 85,21,965 PDAs who have taken their second dose.

The ministry said 2,02,10,889 people in the age group 18 to 44 have received their first dose and 23,491 their second dose.

In addition to them, 6,64,02,012 and 1,07,15,693 beneficiaries in the 45-60 age group have taken their first and second doses, respectively, while 5,88,31,736 and 1,87,74,039 beneficiaries above the age of 60 they have received their first and second doses, respectively.

The ministry said that as of day 136 of the vaccination campaign, a total of 25,52,501 doses of vaccine were administered.

It said 22.75,324 beneficiaries received their first dose and 2,77,177 their second dose, according to the interim report until 7 p.m. Final reports would be completed by the day late in the evening, the ministry said.

The vaccination exercise as a tool to protect the country’s most vulnerable population groups from COVID-19 continues to be regularly reviewed and monitored at the highest level, he said.